# A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)

> **NCT00124735** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 149 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Rocuronium bolus maintenance
- **DRUG:** rocuronium continuous infusion maintenance

## Key facts

- **NCT ID:** NCT00124735
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-08
- **Final completion:** 2007-09
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2016-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00124735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00124735, "A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00124735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*